107 related articles for article (PubMed ID: 33544997)
21. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.
Auranen A; Song H; Waterfall C; Dicioccio RA; Kuschel B; Kjaer SK; Hogdall E; Hogdall C; Stratton J; Whittemore AS; Easton DF; Ponder BA; Novik KL; Dunning AM; Gayther S; Pharoah PD
Int J Cancer; 2005 Nov; 117(4):611-8. PubMed ID: 15924337
[TBL] [Abstract][Full Text] [Related]
22. Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia.
Ramzi M; Arandi N; Saadi MI; Yaghobi R; Geramizadeh B
Exp Clin Transplant; 2020 Nov; 18(6):719-724. PubMed ID: 29697355
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the influence of chronic low-dose radiation on DNA repair gene polymorphisms [
Saini D; Sudheer KR; Kumar PRV; Soren DC; Jain V; Koya PKM; Jaikrishan G; Das B
Int J Radiat Biol; 2020 Jun; 96(6):734-739. PubMed ID: 32149571
[No Abstract] [Full Text] [Related]
24. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
25. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
Maruei-Milan R; Heidari Z; Salimi S
J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population.
Zhang Z; Wan J; Jin X; Jin T; Shen H; Lu D; Xia Z
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2614-9. PubMed ID: 16284386
[TBL] [Abstract][Full Text] [Related]
28. Association of Arg194Trp, Arg280His and Arg399Gln polymorphisms in X-ray repair cross-complementing group 1 gene and risk of differentiated thyroid carcinoma in Iran.
Fard-Esfahani P; Fard-Esfahani A; Fayaz S; Ghanbarzadeh B; Saidi P; Mohabati R; Bidoki SK; Majdi M
Iran Biomed J; 2011; 15(3):73-8. PubMed ID: 21987112
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in DNA repair genes and risk of glioma and meningioma.
Luo KQ; Mu SQ; Wu ZX; Shi YN; Peng JC
Asian Pac J Cancer Prev; 2013; 14(1):449-52. PubMed ID: 23534771
[TBL] [Abstract][Full Text] [Related]
30. Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women.
Rah H; Jeon YJ; Lee BE; Kim JO; Shim SH; Lee WS; Choi DH; Kim JH; Kim NK
Menopause; 2013 Oct; 20(10):1067-73. PubMed ID: 23549446
[TBL] [Abstract][Full Text] [Related]
31. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
Hashemi M; Danesh H; Bizhani F; Narouie B; Sotoudeh M; Nouralizadeh A; Sharifiaghdas F; Bahari G; Taheri M
Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526
[TBL] [Abstract][Full Text] [Related]
32. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
[TBL] [Abstract][Full Text] [Related]
33. The TP53 intron 6 G13964C polymorphism and risk of thyroid and breast cancer development in the Iranian Azeri population.
Dehghan R; Hosseinpour Feizi MA; Pouladi N; Adampourezare M; Farajzadeh D
Asian Pac J Cancer Prev; 2015; 16(7):3073-7. PubMed ID: 25854408
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
35. The effects of DICER1 and DROSHA polymorphisms on susceptibility to recurrent spontaneous abortion.
Ghasemi M; Rezaei M; Yazdi A; Keikha N; Maruei-Milan R; Asadi-Tarani M; Salimi S
J Clin Lab Anal; 2020 Mar; 34(3):e23079. PubMed ID: 31659796
[TBL] [Abstract][Full Text] [Related]
36. Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer.
García-Quispes WA; Pérez-Machado G; Akdi A; Pastor S; Galofré P; Biarnés F; Castell J; Velázquez A; Marcos R
Mutat Res; 2011 May; 709-710():67-72. PubMed ID: 21414327
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
38. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer.
Gao LB; Li LJ; Pan XM; Li ZH; Liang WB; Bai P; Zhu YH; Zhang L
Biol Chem; 2013 Mar; 394(3):415-20. PubMed ID: 23183747
[TBL] [Abstract][Full Text] [Related]
39. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
Bashir K; Sarwar R; Saeed S; Mahjabeen I; Kayani MA
PLoS One; 2018; 13(9):e0199007. PubMed ID: 30183716
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
